574
Views
42
CrossRef citations to date
0
Altmetric
Original Research

Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis

, , , , &
Pages 275-283 | Published online: 04 Jul 2018

References

  • HaenischBWalstabJHerberholdSAlpha-adrenoceptor agonistic activity of oxymetazoline and xylometazolineFundam Clin Pharmacol201024672973920030735
  • HamiltonLHEffect of xylometazoline nasal spray on nasal conductance in subjects with coryzaJ Otolaryngol19811021091166165826
  • WilliamsRGEcclesRNasal airflow asymmetry and the effects of a topical nasal decongestantRhinology19923042772821281924
  • CastellanoFMautoneGDecongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect studyDrugs Exp Clin Res2002281273512073765
  • CohenSMItoNA critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tractCrit Rev Toxicol200232541344412389870
  • MichelGNyval-CollenPBarbeyronTCzjzekMHelbertWBio-conversion of red seaweed galactans: a focus on bacterial agarases and carrageenasesAppl Microbiol Biotechnol2006711233316550377
  • CarlucciMJCianciaMMatulewiczMCCerezoASDamonteEBAntiherpetic activity and mode of action of natural carrageenans of diverse structural typesAntiviral Res19994329310210517311
  • TalaricoLBDamonteEBInterference in dengue virus adsorption and uncoating by carrageenansVirology2007363247348517337028
  • GonzálezMEAlarcónBCarrascoLPolysaccharides as antiviral agents: antiviral activity of carrageenanAntimicrob Agents Chemother1987319138813932823697
  • BuckCBThompsonCDRobertsJNMüllerMLowyDRSchillerJTCarrageenan is a potent inhibitor of papillomavirus infectionPLoS Pathog200627e6916839203
  • CarlucciMJScolaroLANosedaMDCerezoASDamonteEBProtective effect of a natural carrageenan on genital herpes simplex virus infection in miceAntiviral Res200464213714115498610
  • PujolCAScolaroLACianciaMMatulewiczMCCerezoASDamonteEBAntiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infectionPlanta Med200672212112516491446
  • BabaMSnoeckRPauwelsRde ClercqESulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrob Agents Chemother19883211174217452472775
  • TalaricoLBPujolCAZibettiRGThe antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cellAntiviral Res2005662–310311015911027
  • TurvilleSGAravantinouMMillerTEfficacy of Carraguard-based microbicides in vivo despite variable in vitro activityPLoS One200839e316218776937
  • KilmarxPHBlanchardKChaikummaoSA randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in ThailandSex Transm Dis200835322623218490865
  • GirondSCranceJMvan Cuyck-GandreHRenaudetJDeloinceRAntiviral activity of carrageenan on hepatitis A virus replication in cell cultureRes Virol199114242612701665574
  • DamonteEBMatulewiczMCCerezoASSulfated seaweed polysaccharides as antiviral agentsCurr Med Chem200411182399241915379705
  • GhoshTChattopadhyayKMarschallMKarmakarPMandalPRayBFocus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluationGlycobiology200919121518815291
  • WitvrouwMDe ClercqESulfated polysaccharides extracted from sea algae as potential antiviral drugsGen Pharmacol19972944975119352294
  • GrassauerAWeinmuellnerRMeierCPretschAPrieschl-GrassauerEUngerHIota-carrageenan is a potent inhibitor of rhinovirus infectionVirol J2008510718817582
  • LeibbrandtAMeierCKönig-SchusterMIota-carrageenan is a potent inhibitor of influenza A virus infectionPLoS One2010512e1432021179403
  • EcclesRMeierCJawadMWeinmüllnerRGrassauerAPrieschl-GrassauerEEfficacy and safety of an antiviral iota-carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common coldRespir Res20101110820696083
  • FazekasTEickhoffPPrucknerNLessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common coldBMC Complement Altern Med20121214722950667
  • LudwigMEnzenhoferESchneiderSEfficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trialRespir Res20131412424219370
  • KoenighoferMLionTBodenteichACarrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trialsMultidiscip Respir Med2014915725411637
  • Morokutti-KurzMGrafCPrieschl-GrassauerEAmylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throatInt J Gen Med201710536028280379
  • GreimelABernkop-SchnürchADel CurtoMDD’AntonioMTransport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosaDrug Dev Ind Pharm2007331717717192253
  • WilsonTDSteckWFA modified HET-CAM assay approach to the assessment of anti-irritant properties of plant extractsFood Chem Toxicol2000381086787211039320
  • PaperDHKarallEKremserMKrennLComparison of the antiinflammatory effects of Drosera rotundifolia and Drosera madagascariensis in the HET-CAM assayPhytother Res200519432332616041727
  • LuepkeNPHen’s egg chorioallantoic membrane test for irritation potentialFood Chem Toxicol19852322872914040077
  • VinardellMPMaciánMComparative study of the HET-CAM test and the Draize eye test for assessment of irritancy potentialToxicol In Vitro19948346747020692940
  • NicholsWGPeck CampbellAJBoeckhMRespiratory viruses other than influenza virus: impact and therapeutic advancesClin Microbiol Rev2008212274290 table of contents18400797
  • HebarAKollerCSeifertJMNon-clinical safety evaluation of intranasal iota-carrageenanPLoS One2015104e012291125875737
  • AndersenICamnerPJensenPLPhilipsonKProctorDFA comparison of nasal and tracheobronchial clearanceArch Environ Health19742952902934472935